FDA officials asked to step down after contentious Alzheimer’s drug approval
Three experts resigned in protest. Watchdog says it's FDA brass that should leave.
Full Article
FDA officials asked to step down after contentious Alzheimer’s drug approval
Ars Technica
0 shares
1 views
You might like
Related news coverage
FDA officials should resign over 'reckless' approval of Biogen Alzheimer’s drug, says US consumer rights group
Proactive Investors
A US consumer rights group has said the acting commissioner of the Food and Drug Administration (FDA) Janet Woodcock and other..
Advertisement
More coverage
FDA Approves Highly Debated Alzheimer’s Drug
Newsy
Watch VideoGovernment health officials on Monday approved the first new drug for Alzheimer's disease in nearly 20 years,..